Reduce Price to Improve Revenues and Margins

CHOICE 1 OBJECTIVE: RETAIN CUSTOMERS

CHOICE 2 SEGMENTS: PUBLIC RELATIONS SEGMENT / IMPROVE THE COMPANY'S IMAGE

CHOICE 3 COMPONENT: CHANGE THE LIST PRICE

No. SIC Year Notes
1 2834 2009 GlaxoSmithKline PLC, the world's second-biggest drug maker by sales, plans to cut prices in the world's poorest countries and invest 20% of its profit from those markets into building health clinics and other infrastructure. Glaxo's treatments for hepatitis B, general herpes, malaria and asthma are among those that will be subject to price cuts, a Glaxo spokesman said. Glaxo already sells its HIV drugs in these countries at not-for-profit prices, and if those prices aren't already lower than 25% of the developed-world price, they will be reduced, as well, she said.

<< Return to Choice 3